Updates from The Motley Fool

Latest updates on Juno Therapeutics from Fool.com.  The Fool has written over 100 articles on Juno Therapeutics.
3 Biotech Stocks to Buy on Sale

Image source: Getty Images. Since last summer, the market has distributed indiscriminate beatings...

CAR-T Stocks: Time to Panic?

Image source: Getty Images. What: Shares of the chimeric antigen receptor (CAR) transduced T cel...

Stock Performance

View Interactive JUNO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Juno Therapeutics.
Current Price: $26.29
Prev Close: $26.99
Open: $26.99
Bid: $26.33
Ask: $26.53
Day's Range: $26.22 - $27.50
52wk Range: $22.37 - $57.82
Volume: 1,104,220
Avg Vol 1,551,213
Market Cap: $3B
P/E (ttm): -10.84
EPS (ttm): ($2.49)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Juno Therapeutics.
CAPS Rating 4 out of 5
166 Outperform
6 Underperform
CAPS All Stars
40 Outperform
3 Underperform

How do you think Juno Therapeutics will perform against the market?

You pick for Juno Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Hans Bishop, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Juno Therapeutics.


  • Exchange: NASDAQ